pd 169316 has been researched along with Enterovirus Infections in 1 studies
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor
Enterovirus Infections: Diseases caused by ENTEROVIRUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Z | 1 |
| Wang, B | 1 |
| Wu, S | 1 |
| Wen, Y | 1 |
| Wang, X | 1 |
| Song, X | 1 |
| Zhang, J | 1 |
| Hou, L | 1 |
| Chen, W | 1 |
1 other study available for pd 169316 and Enterovirus Infections
| Article | Year |
|---|---|
PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71.
Topics: Animals; Antiviral Agents; Apoptosis; Enterovirus A, Human; Enterovirus Infections; Enzyme Inhibitor | 2017 |